abstract |
A compound of formula I, wherein A, R 1a , R 1b , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R a , R b , X 1 , X 2 , X 3 and n are inhibitors of PAK1 as defined herein. Compositions and methods for treating cancer and hyperproliferative disorders are also disclosed. |